Search:

Exact Keyword


Total 593 results.
Sort by Relevant
Global Markets for Oxygen Therapy and Inhalation Devices (2015)
94 Pages | 57 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
The global market for oxygen therapy and inhalation devices was valued at $1.0 billion in 2014. As analyzed in this detailed new report by LSI, growth in developed markets, such as the U.S., has been profoundly shaped by trends in reimbursement. While cost-containment efforts by providers have threatened product manufacturers' margins, they have also spurred the adoption of technologies that reduce the need for frequent visits and facilitate more flexible lifestyles for patients, trends which...[Read More]




2015 Global Opportunities in Endovascular Management of Chronic Venous Insufficiency & Deep Vein Thrombosis (2015)
200 Pages | Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Chronic venous insufficiency (CVI) and deep vein thrombosis (DVT) are complex and challenging peripheral vascular conditions that affecting large segments of the global adult population. Although not usually as immediately life-threatening as a stroke or heart attack, their progressive nature can have serious long-term implications for affected individuals, who may develop debilitating secondary conditions that can be costly to treat and, in some cases, become life-threatening. Aside from l...[Read More]




U.S. Markets for Drug and Fluid Delivery Devices (2015)
180 Pages | 52 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S. To date, more than 40,000 prescription drug products containing 2,700 active ingredients have been approved by the FDA; these products accounted for more than 70% of the national pharmaceutical usage in 2014. In the same year, U.S. pharmacies processed nearly 4 billion prescriptions, generating more than $310.0 billion in cumu...[Read More]




Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies (2015)
106 Pages | 44 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
A new report from LSI, "Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies in 2015," explores the dynamic market for transdermal drug patches, iontophoresis devices, dry powder inhalers, metered dose inhalers, and nebulizers. The market, which was valued at $8.2 billion in 2014, is being driven by powerful regional and economic forces; key among these are the introduction and adoption of generic products, rising caseloads, the pursuit of new and expanded t...[Read More]




U.S. Markets for Obesity Drugs & Devices (2015)
178 Pages | 56 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
According to National Health and Nutrition Examination Survey (NHANES), approximately 35%, or nearly one out of three adults age 20 years or older were classified as obese in 2012 (the latest available statistics) based on a BMI of 30 kg/m2 or greater. This translates to more than 100 million obese people in the U.S.-a staggering number. Obesity has become such as concern due to increasing prevalence and the rise of serious health-related co-morbidities, such as type 2 diabetes, that it has r...[Read More]




U.S. Markets for Stroke Management (2015)
170 Pages | 44 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The United States (U.S.) market for stroke management products, which encompasses diagnostic and therapeutic systems, is a market composed of old and new technologies that are often used together in order to prevent and treat stroke. Improvements in stroke diagnostic systems will facilitate the delivery of timely stroke therapies within the optimum treatment window for patients suffering from stroke. Topics covered in this report include: •    Diagnostic, intervention...[Read More]




U.S. Markets for Biologic and Tissue Engineered Devices - Cardiovascular and Neurological Products (2015)
110 Pages | 13 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
Tissue engineering, or regenerative medicine, represents a promising therapeutic possibility for the treatment of aggressive and deadly diseases. Cellular therapies for cardiovascular disease (CVD) and neurological disease represent potential billion dollar markets that could offer a viable therapeutic option for a sizable patient population that has exhausted other therapeutic alternatives. Over 35 novel cellular therapies for cardiovascular and neurological disease are currently in develo...[Read More]




U.S. Markets for Cardiac Rhythm Management (2015)
118 Pages | 33 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it. Over the forecast period covered in this report, the estimated value of the U.S. market for CRM devices is expected to grow by approximately $1.1 billion at compound annual growth rate (CAGR) of 2.9%; of this holistic market, diagnostic CRM products are forecasted to grow at a CAGR of 4.8%,...[Read More]




Global Molecular Diagnostics Market (2015)
272 Pages | 59 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019. This growth is forecast to occur in spite of relatively modest growth in the overall worldwide market for IVD products, which is estimated to be expanding at a compound annual rate of 4.2% for the same period. To some extent, growth o...[Read More]




2015 Global Opportunities in Interventional Acute Stroke Therapies (2015)
200 Pages | Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The report covers emerging and existing neurointerventional technologies used in the management of patients with intracranial hemorrhage and acute cerebral ischemia. Special emphasis is given to novel left atrial appendage systems for the prevention of cardiogenic stroke (which accounts for about 20% of all acute ischemic stroke cases), and cerebral thrombectomy systems that address a large unmet need in the emergent treatment of acute ischemic stroke patients (less than 5% of the latter qua...[Read More]




2015 Global Opportunities in the Interventional Management of Symptomatic Peripheral Artery Disease (2015)
200 Pages | 66 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
This report focuses on the novel drug-coated balloon and drug-eluting stent technologies that are expected to revolutionize the treatment of limb- and life-threatening symptomatic peripheral artery disease and drive the development of a new, multi-billion dollar market. It also covers revascularization-enabling peripheral atherectomy systems and dedicated refractory CTO crossing devices that are likely to see above-average growth through 2019. Epidemiological, procedure and market data are ...[Read More]




2015 Global Opportunities in Endovascular Management of Aortic Aneurysm Disease (2015)
200 Pages | Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
This report is focused on primary and ancillary technologies employed in endovascular aortic aneurysm repair (EVAR). Commercially introduced about two decades ago, less invasive EVAR techniques quickly emerged as the preferred treatment modality for life-threatening, rupture-prone abdominal and thoracic aortic aneurisms in the U.S. and as a viable alternative to highly invasive and risky surgery in Europe and other regions of the world. By the end of 2014, cumulative global EVAR device revenu...[Read More]




U.S. Markets for Minimally Invasive Benign Prostatic Hyperplasia and Prostatitis Therapies (2015)
74 Pages | 15 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
In the United States (U.S.) benign prostatic hyperplasia (BPH) and prostatitis currently affect over 10 million men, lowering quality of life with painful symptoms that can be difficult to manage. The U.S. market for minimally invasive products for the treatment of BPH and prostatitis includes pharmaceutical and minimally invasive surgical systems aimed at treating the symptoms of BPH/prostatitis. New therapies in development offer the potential to change the way that symptomatic BPH and pr...[Read More]




U.S. Markets for Orthopedic Extremity and Soft Tissue Repair (2015)
138 Pages | 46 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The United States (U.S.) market for orthopedic extremity and soft tissue repair products encompasses interventional surgical procedures and biologic and synthetic implants used in the repair of bone, joints, and soft tissue that have been damaged as a result of disease or due to physical injury. Innovation in the treatment of bone, joint, and soft tissue of the extremities will primarily be seen in biologics, as new products are designed harnessing cellular therapies, such as stem cells, to ...[Read More]




U.S. Markets for Anesthesia and Ventilation Products (2015)
184 Pages | 62 Exhibits | 2015 Analysis | Forecasts Through 2018 | Relavancy 1
Respiratory care and anesthesia represent a significant element of healthcare delivery within the U.S. In 2013, the U.S. anesthesia and ventilation products market totaled approximately $3.5 billion. The overall market is expected to experience 4.5% growth over the forecast period, with the most growth anticipated in the heat/moisture exchangers and supraglottic airways segments. Factors contributing to growth in this market include the aging of the population (with an associated incre...[Read More]




2015 Hypertension and Resistant Hypertension Disease Dynamics Report (2015)
Pages | Exhibits | 2015 Analysis | Forecasts Through | Relavancy 1
In this report, Dymedex provides a detailed landscape of diseases far beyond what is currently available in the public domain. While individual clinical papers provide specific snapshots of a disease or strive to understand its epidemiology or other dimensions, no single clinical paper attempts to aggregate the hundreds of pieces of information that exist about a given disease and synthesize them into an integrated perspective. This report details the progression of a patient from undia...[Read More]




Global Markets for Gastrointestinal and Colorectal Endoscopy, Cystoscopy, Ureteroscopy, and Hysteroscopy (2015)
104 Pages | 67 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
This report explores the underlying forces driving growth in some of the most important endoscopic segments. At a time when healthcare institutions are seeking ways to restrain spending while improving outcomes, endoscopic technologies offer compelling possibilities by presenting improvements in cosmetic outcomes and the potential for faster recoveries-both of which are important considerations in a global market which features a growing middle class and rising awareness of th...[Read More]




Global Markets for Specialty Surgical Endoscopy Products (2015)
101 Pages | 62 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
The trend toward minimally-invasive surgery has driven rising sales of endoscopy products in a growing range of applications, including orthopedics, pulmonary and respiratory applications, urology, otolaryngology, gastrointestinal and colorectal surgery, neurology, and gynecology. Technological limitations and major anatomical challenges have limited adoption in important categories, however, preventing broader use of endoscopic devices and techniques for life-threatening applications in surg...[Read More]




Global Markets for Arthroscopy, Bronchoscopy, ENT Endoscopy, Neuroendoscopy, and Spinal Endoscopy (2015)
109 Pages | 73 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
Robust growth is expected for sales of minimally invasive surgical products through 2020. The market, which was valued at $8.4 billion in 2014 and includes arthroscopes, bronchoscopes, endoscopes, instrumentation, access devices, and related products is benefiting from the adoption of new devices and techniques that expand the range of surgical caseloads; patient and clinical preference for less-invasive surgical methods; and rising access to advanced technologies in emerging markets. This an...[Read More]




U.S. Markets for Advanced Wound Care Products (2015)
143 Pages | 31 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Over the past 20 years, there has been an explosion of knowledge regarding the basic science of wound healing and a trend toward more evidence-based medicine. Advanced wound care technologies that have been developed include tissue-engineered skin replacement/substitutes, active wound repair modulators, advanced wound closure products, and advanced wound dressings. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and oppo...[Read More]




Emerging Global Markets for Novel Peripheral Interventional and Neurointerventional Therapeutic Systems (2015)
189 Pages | 49 Exhibits | 2015 Analysis | Forecasts Through 2018 | Relavancy 1
Peripheral vascular disease and acute stroke are major public health problems worldwide, and the incidence and prevalence of these conditions is rising, reflecting both the aging of the population in many regions of the world, and continuing growth in the incidence of problematic risk factors such as diabetes, hypertension and obesity. In recent years, device manufacturers have developed a number of novel and highly promising percutaneous revascularization technologies including peripheral d...[Read More]




Global Markets for Drug Delivery: Infusion and Injection Technologies (2015)
111 Pages | 71 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
Infusion and injection technologies generated $14.2 billion in global sales during 2014. As discussed in LSI's new report, "Global Markets for Drug Delivery: Infusion and Injection Technologies in 2015," the market for these products-which include infusion systems, vascular access devices, and injection products- will be affected by critical regional factors that include initiatives to expand access to healthcare, limit the cost of expensive critical and long-term care, and improve convenienc...[Read More]




2015 Opportunities in Global Medical Devices & Diagnostics (2015)
557 Pages | 200 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The $379 billion global medical devices and diagnostics (MD&D) industry has been undergoing significant globalization and consolidation as industrialized nations seek to provide more care for fewer dollars and emerging nations strive to better serve the health care needs of new urban classes driving their economic growth. Although market growth is unlikely to return to former double-digit levels, significant opportunities in new technologies, geographies and strategic merger & acquisition (M&...[Read More]




2015 Worldwide Markets and Emerging Technologies for Point-of-Care Testing (2015)
307 Pages | 129 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The market for point-of-care (POC) diagnostic products comprises 28% of the total in-vitro diagnostics market. The market is projected to grow at a considerably slower rate than the overall IVD market over the 2014-2019 interval, primarily due to stagnant sales in the whole blood glucose self-testing segment, which accounts for more than half (53%) of the total market. However, most other segments of the POC diagnostics market are growing at rates well in excess of the overall POC market, and...[Read More]




U.S. Markets for Orthopedic Biologic and Tissue Engineered Products (2015)
116 Pages | 27 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Biologics and cellular therapies for musculoskeletal injuries-including hard tissue (i.e., bone) and soft tissue (i.e., cartilage, ligaments, and tendons)-represent a billion dollar market that is showing the potential for continued growth. Over the forecast period covered in this report, the estimated value of the U.S. market for orthopedic biologic and tissue engineered products is expected to grow by approximately $984.4 million at a compound annual growth rate (CAGR) of 8.2%; of this hol...[Read More]




Global Markets for Peripheral Endovascular and Vascular Closure Devices (2015)
344 Pages | 171 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Percutaneous transluminal angioplasty will lead the way with double-digit annual growth, driving expansion in U.S. and international markets. Robust market growth is expected for several peripheral endovascular and vascular closure devices on a global basis. Endovascular therapies have seen rising adoption due to new product introductions, the increasing prevalence of peripheral artery disease, developing healthcare systems in emerging markets, and the desire to utilize minimally invasive...[Read More]




Global Markets for Surgical Drapes, Gowns, Gloves, Masks, and Fluid Management Products (2015)
94 Pages | 46 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
The global market for surgical drapes and gowns, gloves, masks, and fluid management products was valued at $9.5 billion in 2014. As analyzed in this detailed new analysis by LSI, the market will be influenced by efforts to limit health care costs through the reduction of infections and product expenditures as well as the need to accommodate the rising number of surgeries in key markets. Trends in product utilization, such as double-gloving, will generate growth in the number of units sold ea...[Read More]




International Markets for Specialty Peripheral Vascular Products (2015)
85 Pages | 41 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The international market for atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices was valued at $733 million during 2013. This new report from Life Science Intelligence explores the market for these devices in Europe, Asia-Pacific and the rest of the world and analyzes key factors influencing the international market, such as how clinical studies in support of product approvals in the U.S. could affect uptake and utilization in Europe; the e...[Read More]




U.S. Markets for Specialty Peripheral Vascular Products (2015)
72 Pages | 31 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices accounted for $836 million in U.S. sales during 2013. As discussed in Life Science Intelligence's new report, strong growth is expected in the U.S. market in coming years due to clinical efforts to improve the effectiveness of interventional methods for treating peripheral artery disease (PAD); attempts to refine techniques; and the impact of new products such as drug-coated balloons (DCBs...[Read More]




U.S. Markets for Critical Care Patient Management Products (2014)
179 Pages | 50 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Critical care in the U.S. is expanding rapidly, particularly as hospital lengths of stay decrease, and the intensity of care and acuity of patients admitted to hospitals increase. Hospitals are evolving into critical care centers to which only the most seriously ill patients are admitted. Virtually every hospital unit has a significant percentage of patients benefiting from advanced technologies and equipment necessary for sustaining life, or for rapidly identifying severe clinical conditio...[Read More]




Contact Us

Need help finding medtech research? Let us help you!